# ZNF521

## Overview
ZNF521 is a gene that encodes the zinc finger protein 521, a transcriptional co-regulator characterized by its 30 Kruppel-like C2H2-type zinc finger motifs. This protein is primarily involved in the regulation of gene expression and plays a significant role in various cellular differentiation processes, particularly within hematopoietic and mesenchymal stem cells. Zinc finger protein 521 is known for its ability to interact with other transcription factors, such as GATA-1 and early B-cell factor 1 (EBF1), thereby modulating pathways critical for cell fate determination. It is also implicated in the Sonic Hedgehog signaling pathway, influencing neural development and tumorigenesis. The dysregulation of ZNF521 expression has been associated with several malignancies, including leukemias, medulloblastomas, and epithelial ovarian carcinoma, highlighting its potential as a therapeutic target (Scicchitano2019The; Chiarella2021Regulatory; Mega2011Zinc).

## Structure
ZNF521, also known as zinc finger protein 521, is a nuclear factor composed of 1311 amino acids and features 30 Kruppel-like zinc finger (ZF) motifs distributed in clusters throughout the protein (Bond2008Early). These zinc fingers are C2H2-type, which are common in DNA-binding proteins and contribute to the protein's secondary and tertiary structures. The protein's structure includes a 12-amino acid motif at the N-terminal end, which is conserved among transcriptional co-repressors and interacts with the nucleosome remodeling and histone deacetylation (NuRD) complex (Bond2008Early; Mega2011Zinc). This motif is crucial for its repressive function and is associated with transcriptional repression (Matsubara2009The).

ZNF521's carboxyl-terminal portion is necessary for binding to early B-cell factor 1 (EBF1), with specific zinc fingers (ZF 24-30) retaining this binding ability (Mega2011Zinc). The protein can exist in different splice variant isoforms, although attempts to identify an isoform lacking the NuRD-binding motif have been unsuccessful (Bond2008Early). ZNF521 is also subject to post-translational modifications, such as phosphorylation, which may influence its function and interactions.

## Function
ZNF521 (zinc finger protein 521) is a transcription co-factor involved in various cellular processes in healthy human cells. It is composed of 30 zinc fingers organized in five domains and an N-terminal transcriptional repressor motif. ZNF521 is abundantly expressed in hematopoietic stem/progenitor cells and plays a crucial role in maintaining their multipotency by modulating differentiation pathways (Chiarella2021Regulatory; Mega2011Zinc).

In the hematopoietic system, ZNF521 functions as a repressor of erythroid differentiation by inhibiting GATA-1 and attenuates B-lymphoid differentiation by antagonizing Early B-cell factor 1 (EBF1). This antagonism is achieved through the binding of ZNF521 to EBF1, which inhibits EBF1's transcriptional activity and affects the expression of EBF1 target genes (Mega2011Zinc). ZNF521's interaction with epigenetic effectors, such as histone deacetylases, may influence chromatin modifications and gene expression, further contributing to its regulatory role (Mega2011Zinc).

In the mesenchymal system, ZNF521 delays and represses adipocyte and osteoblastic differentiation by inhibiting transcription factors such as ZNF423, C/EBPα, PPARγ, and RUNX2. This regulatory function is crucial for maintaining the immature compartment of mesenchymal stem cells (Chiarella2018ZNF521; Chiarella2021Regulatory). ZNF521 is also involved in neural development and bone formation, highlighting its role in cell fate determination across different progenitor cell types (Chiarella2021Regulatory).

## Clinical Significance
ZNF521 is implicated in several diseases due to its role as a transcription co-factor. In hematological malignancies, ZNF521 acts as a negative regulator of B-cell differentiation, and its inappropriate expression may contribute to B lymphoid neoplasias, such as leukemias and lymphomas. A chromosomal aberration involving ZNF521 in human B-ALL results in a PAX5/ZNF521 fusion transcript, potentially contributing to leukemia pathogenesis (Mega2011Zinc). In acute myeloid leukemia (AML), ZNF521 is overexpressed, particularly in cases with MLL rearrangements, enhancing leukemic cell growth and self-renewal (Chiarella2021ZNF521).

In medulloblastoma, ZNF521 is highly expressed in subgroups with dysregulated Sonic Hedgehog (SHH) pathways, supporting tumor growth and migration by interacting with GLI1 and GLI2 (Scicchitano2019The). In epithelial ovarian carcinoma, ZNF521 overexpression is associated with poor prognosis and aggressive tumor behavior, linked to its interaction with the NRF2 and NOTCH signaling pathways (Scicchitano2022Enhanced; Scicchitano2023Zinc). In hepatocellular carcinoma, ZNF521 is downregulated, acting as a tumor suppressor by inhibiting cell proliferation and promoting apoptosis (Yang2020ZNF521). These findings highlight ZNF521's potential as a therapeutic target in various cancers.

## Interactions
ZNF521 is known to interact with several proteins, influencing various cellular processes. It physically interacts with the transcription factor GATA-1, inhibiting its transcriptional activity without affecting its DNA binding ability. This interaction is crucial for modulating erythroid differentiation, as demonstrated by pulldown assays using GST fusion proteins and His-tagged ZNF521 fragments (Matsubara2009The).

ZNF521 also interacts with GLI1 and GLI2, components of the Sonic Hedgehog (SHH) signaling pathway. This interaction enhances the transcriptional activity of GLI-binding regulatory sequences, particularly in the SHH subgroup of medulloblastomas. The cooperation between ZNF521 and GLI1 requires the recruitment of the HDAC-NuRD complex, facilitated by a specific motif at the N-terminal end of ZNF521 (Scicchitano2019The).

In the context of B-lymphoid differentiation, ZNF521 interacts with early B-cell factor 1 (EBF1), inhibiting its transcriptional activity. This interaction is mediated by the carboxyl-terminal zinc fingers of ZNF521, as shown in co-immunoprecipitation assays (Mega2011Zinc). These interactions highlight ZNF521's role as a transcriptional co-regulator, influencing various pathways and cellular differentiation processes.


## References


[1. (Chiarella2018ZNF521) Emanuela Chiarella, Annamaria Aloisio, Bruna Codispoti, Giovanna Nappo, Stefania Scicchitano, Valeria Lucchino, Ylenia Montalcini, Augusto Camarotti, Olimpio Galasso, Manfredi Greco, Giorgio Gasparini, Maria Mesuraca, Heather Mandy Bond, and Giovanni Morrone. Znf521 has an inhibitory effect on the adipogenic differentiation of human adipose-derived mesenchymal stem cells. Stem Cell Reviews and Reports, 14(6):901–914, June 2018. URL: http://dx.doi.org/10.1007/s12015-018-9830-0, doi:10.1007/s12015-018-9830-0. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12015-018-9830-0)

[2. (Chiarella2021ZNF521) Emanuela Chiarella, Annamaria Aloisio, Stefania Scicchitano, Katia Todoerti, Emanuela G. Cosentino, Daniela Lico, Antonino Neri, Nicola Amodio, Heather Mandy Bond, and Maria Mesuraca. Znf521 enhances mll-af9-dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape. International Journal of Molecular Sciences, 22(19):10814, October 2021. URL: http://dx.doi.org/10.3390/ijms221910814, doi:10.3390/ijms221910814. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms221910814)

[3. (Scicchitano2019The) Stefania Scicchitano, Marco Giordano, Valeria Lucchino, Ylenia Montalcini, Emanuela Chiarella, Annamaria Aloisio, Bruna Codispoti, Pietro Zoppoli, Valentina Melocchi, Fabrizio Bianchi, Enrico De Smaele, Maria Mesuraca, Giovanni Morrone, and Heather M. Bond. The stem cell-associated transcription co-factor, znf521, interacts with gli1 and gli2 and enhances the activity of the sonic hedgehog pathway. Cell Death &amp; Disease, September 2019. URL: http://dx.doi.org/10.1038/s41419-019-1946-x, doi:10.1038/s41419-019-1946-x. This article has 18 citations.](https://doi.org/10.1038/s41419-019-1946-x)

[4. (Matsubara2009The) Etsuko Matsubara, Ikuya Sakai, Jun Yamanouchi, Hiroshi Fujiwara, Yoshihiro Yakushijin, Takaaki Hato, Kazuhiro Shigemoto, and Masaki Yasukawa. The role of zinc finger protein 521/early hematopoietic zinc finger protein in erythroid cell differentiation. Journal of Biological Chemistry, 284(6):3480–3487, February 2009. URL: http://dx.doi.org/10.1074/jbc.M805874200, doi:10.1074/jbc.m805874200. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M805874200)

[5. (Chiarella2021Regulatory) Emanuela Chiarella, Annamaria Aloisio, Stefania Scicchitano, Heather Mandy Bond, and Maria Mesuraca. Regulatory role of micrornas targeting the transcription co-factor znf521 in normal tissues and cancers. International Journal of Molecular Sciences, 22(16):8461, August 2021. URL: http://dx.doi.org/10.3390/ijms22168461, doi:10.3390/ijms22168461. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22168461)

[6. (Mega2011Zinc) Tiziana Mega, Michela Lupia, Nicola Amodio, Sarah J. Horton, Maria Mesuraca, Daniela Pelaggi, Valter Agosti, Michele Grieco, Emanuela Chiarella, Raffaella Spina, Malcolm A.S. Moore, Jan Jacob Schuringa, Heather M. Bond, and Giovanni Morrone. Zinc finger protein 521 antagonizes early b-cell factor 1 and modulates the b-lymphoid differentiation of primary hematopoietic progenitors. Cell Cycle, 10(13):2129–2139, July 2011. URL: http://dx.doi.org/10.4161/cc.10.13.16045, doi:10.4161/cc.10.13.16045. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.10.13.16045)

[7. (Yang2020ZNF521) Nan Yang, Liang Wang, Tianxiang Chen, Runkun Liu, Zhikui Liu, and Lei Zhang. Znf521 which is downregulated by mir-802 suppresses malignant progression of hepatocellular carcinoma through regulating runx2 expression. Journal of Cancer, 11(19):5831–5839, 2020. URL: http://dx.doi.org/10.7150/jca.45190, doi:10.7150/jca.45190. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.45190)

[8. (Scicchitano2022Enhanced) Stefania Scicchitano, Ylenia Montalcini, Valeria Lucchino, Valentina Melocchi, Valerio Gigantino, Emanuela Chiarella, Fabrizio Bianchi, Alessandro Weisz, and Maria Mesuraca. Enhanced znf521 expression induces an aggressive phenotype in human ovarian carcinoma cell lines. PLOS ONE, 17(10):e0274785, October 2022. URL: http://dx.doi.org/10.1371/journal.pone.0274785, doi:10.1371/journal.pone.0274785. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0274785)

[9. (Bond2008Early) Heather M. Bond, Maria Mesuraca, Nicola Amodio, Tiziana Mega, Valter Agosti, Delia Fanello, Daniela Pelaggi, Lars Bullinger, Michele Grieco, Malcolm A.S. Moore, Salvatore Venuta, and Giovanni Morrone. Early hematopoietic zinc finger protein—zinc finger protein 521: a candidate regulator of diverse immature cells. The International Journal of Biochemistry &amp; Cell Biology, 40(5):848–854, January 2008. URL: http://dx.doi.org/10.1016/j.biocel.2007.04.006, doi:10.1016/j.biocel.2007.04.006. This article has 51 citations.](https://doi.org/10.1016/j.biocel.2007.04.006)

[10. (Scicchitano2023Zinc) Stefania Scicchitano, Maria Concetta Faniello, and Maria Mesuraca. Zinc finger 521 modulates the nrf2-notch signaling pathway in human ovarian carcinoma. International Journal of Molecular Sciences, 24(19):14755, September 2023. URL: http://dx.doi.org/10.3390/ijms241914755, doi:10.3390/ijms241914755. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241914755)